Morgan Health
Washington, District of Columbia, United StatesFounded 2021
Morgan Health is a business unit of JPMorgan Chase focused on improving the quality, affordability, and equity of employer-sponsored healthcare in the United States. It invests in mid-stage healthcare companies aligned with its mission, backed by a $250 million investment fund.
They made 1 investments in the last 12 months. Average disclosed round size is $94.8M (across 11 rounds with reported amounts).
Portfolio
5
Fund Size
$250M
Top Stage
Series F
Last 12 Mo
5
Team
Dan Hartman
Partner, Investments, Morgan Health
Joe Tobias
Chief Financial Officer, Morgan Health
Katie Bobroske
Head of Data Science & Research, Morgan Health
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Thyme | Series E | $125M | Sep 2026 |
| DDevoted Health, Inc. | Series F | $317M | Jan 2026 |
| DDevoted Health, Inc. | Series F | $317M | Jan 2026 |
| DDevoted Health, Inc. | Series F | $48M | Nov 2025 |
| Thyme | Series D | $97M | Sep 2025 |
 Aradigm | Series A | $20M | Jan 2025 |
| DDevoted Health, Inc. | Series F | $48M | Jan 2025 |
| AAradigm Health | Series A | $20M | Jan 2025 |
| AAradigm Health | Seed | $5M | Jan 2024 |
| EEmbold Health | Series B | $23M | Dec 2021 |
| EEmbold Health | Series B | $23M | Jan 2020 |
Top Co-Investors
Frist Cressey Ventures8 shared
Andreessen Horowitz7 shared
NextView Ventures4 shared
Fearless Fund4 shared
GV4 shared
General Catalyst4 shared
The Private Shares Fund4 shared
Centricus4 shared
Premji Invest4 shared
Cox Enterprises4 shared
Stardust Equity4 shared
Emerson Collective4 shared
CVS Health2 shared
Y Combinator2 shared
Concord Health Partners2 shared
Humana2 shared
AlleyCorp2 shared
Foresite Capital2 shared
J.P. Morgan2 shared
Rough Draft2 shared
Last updated: 14 September 2026